MAPT and Alzheimer disease: Indeed, initial ex vivo research supported the reciprocal relationship O-GlcNAcylation and phosphorylation [6], and analysis of human brain tissue revealed lower levels of tau-specific and overall O-GlcNAc in individuals with AD [7].